Biomedical Science and Research Journals | The Activity of 2,3-Dimethylquinoxaline against Madurella mycetomatis
The Activity of 2,3-Dimethylquinoxaline against Madurella mycetomatis Abstract Objective: Madurella mycetomatis is the most prevalent causative species of the eumycetoma, a chronic progressive neglected tropical disabling infectious disease of the subcutaneous tissue. It carries a significant social and economic burden to the endemic areas. Unfortunately, the available treatment is challenging, requires prolonged therapy, resulting in low cure rates and a high incidence of recurrence. Screening new compounds for antifungal activity against Madurella mycetomatis is needed. Design: In vitro: the susceptibility of a Madurella mycetomatis isolate toward the 2,3-dimethylquinoxaline was determined. In vivo: the efficacy of 2,3-dimethylquinoxaline 1% topical gel against the same strain was evaluated in the BALB/c mouse eumycetoma model (n=6; 6-8 weeks old). Results: 2,3-Dimethylquinoxaline inhibited the growth of Madurella mycetomat...